pTeroPure to Present as Part of VendorWorks Series at SupplySide West

Discussion on the science of pterostilbene: the next generation resveratrol

Oct 13, 2010, 08:00 ET from ChromaDex Corporation

IRVINE, Calif., Oct. 13 /PRNewswire/ -- pTeroPure™, an ingredients division of ChromaDex Corporation (OTC Bulletin Board: CDXC) specializing in high purity resveratrol and pterostilbene for use in the dietary supplement and functional food markets, announced today that Ingredients Brand Manager Jeremy Bartos, Ph.D., will present as part of the VendorWorks series at SupplySide West 2010 in Las Vegas, NV.

Dr. Bartos will discuss pterostilbene, a natural derivative of resveratrol found in small berries such as blueberries and grapes in a presentation entitled, "Pterostilbene, the next generation resveratrol", on Friday, October 22, 2:30 p.m. PT, at VendorWorks stage #10068 in The Venetian & The Sands Expo in Las Vegas, NV.

Like resveratrol, pterostilbene functions as an antioxidant and an anti-aging agent and has been shown to help lower cholesterol and blood glucose levels. Unlike resveratrol, pterostilbene has greatly improved oral adsorption and metabolizes more slowly in the body, allowing more time for its antioxidant activities to take place. The presentation will also focus on the synergism of resveratrol and pterostilbene, and how addition of pterostilbene to existing resveratrol products may enhance their efficacy.

"Pterostilbene has the potential to be one of the most significant new ingredients the dietary supplement field has seen in a long time," said Frank L. Jaksch Jr., cofounder and CEO of ChromaDex. "The science behind the use of pterostilbene as a resveratrol alternative or resveratrol enhancer is sound, and with the advent of the first human clinical study on pterostilbene and our upcoming self-affirmed GRAS study, we expect pterostilbene to quickly spread beyond the dietary supplement industry and into functional foods, beverages and cosmetics."

For more information, visit or

About pTeroPure

pTeroPure was founded as a high-quality raw materials division of ChromaDex as a result of its exclusive worldwide patent rights for pterostilbene based on the technology licensed from the University of Mississippi and the USDA. In addition to high purity all trans pterostilbene and resveratrol, pTeroPure also offers premium curcumin, black currant extract, sclareolide, and caffeic acid phenylester (CAPE). pTeroPure is committed to the science behind each ingredient. For more information, visit or call 949-600-9694.

About ChromaDex

ChromaDex is a leader in the development of phytochemical and botanical reference standards and the creation of associated intellectual property. ChromaDex is committed to sustainable "green chemistry" and provides the dietary supplement, food, beverage, nutraceutical and cosmetic industries with the novel ingredients, analytical tools and services to meet product regulatory, quality, efficacy and safety standards. For more information, visit or follow ChromaDex on Twitter @ChromaDex.

Forward-Looking Statements

Any statements that are not historical facts contained in this release are forward-looking statements. Actual results may differ materially from those projected or implied in any forward-looking statements. Such statements involve risks and uncertainties, including but not limited to: the ability to market, produce and sell the referenced ingredients; risks relating to product and customer demand, market acceptance of our products; the effect of economic conditions both nationally and internationally; the ability to protect our intellectual property rights; the impact of any litigation or infringement actions brought against us; competition from other providers and products; risks in product development; our ability to raise capital to fund continuing operations; the ability to complete transactions; and other factors discussed from time to time in the Company's Securities and Exchange Commission filings. The Company undertakes no obligation to update or revise any forward-looking statement for events or circumstances after the date on which such statement is made except as required by law.

Investor Inquiries

Liviakis Financial Communications, Inc.

John M. Liviakis, President


pTeroPure Contact

Jeremy Bartos

Ingredients Product Manager

10005 Muirlands Blvd, Suite G, Irvine, CA 92618


ChromaDex Contact

Jenny Robles

Administrative Assistant to the CEO

10005 Muirlands Blvd, Suite G, Irvine, CA 92618


Media Contact

Megan Lavine

Canale Communications

3033 5th Ave., Suite 400, San Diego, CA 92103


SOURCE ChromaDex Corporation